PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
P Andersen Selected Research
Tuberculosis
03/2004
Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.
10/2003
Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy.
11/2001
Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
10/2001
Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation.
10/2001
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia.
07/2001
Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.
07/2001
Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine.
07/2001
Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10.
05/2001
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.
05/2001
Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.
03/2001
Tuberculosis subunit vaccine development: on the role of interferon-gamma.
01/2001
Antigen discovery and tuberculosis vaccine development in the post-genomic era.
01/2001
Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis.
12/2000
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia.
11/2000
Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.
03/2000
Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.
Articles by Research Topic
Disease
16
Tuberculosis
03/2004 - 03/2000
5
Bovine Tuberculosis
12/2006 - 06/2000
1
Infection
11/2001
1
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2001
1
Vaccinia
11/2000
Drug/Important Bio-Agent (IBA)
12
Antigens
IBA
12/2006 - 03/2000
5
Interferon-gamma (Interferon, gamma)
IBA
10/2003 - 03/2001
2
Tuberculin (PPD)
IBA
11/2001 - 05/2001
1
dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)
IBA
03/2004
1
Subunit Vaccines
IBA
03/2004
1
Cord Factors
IBA
03/2004
1
Recombinant Proteins
IBA
11/2003
1
Peptides
IBA
11/2003
1
DNA (Deoxyribonucleic Acid)
IBA
07/2001
1
Interleukin-6 (Interleukin 6)
IBA
07/2001
1
Messenger RNA (mRNA)
IBA
05/2001
1
Proteins (Proteins, Gene)
IBA
11/2000
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
11/2000
1
AG 85
IBA
11/2000
1
Protein Sorting Signals (Signal Peptide)
IBA
11/2000
Therapy/Procedure
1
Drug Therapy (Chemotherapy)
10/2003